Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
29 USD | +1.77% | +4.47% | +3.39% |
May. 17 | Sector Update: Health Care Stocks Softer Friday Afternoon | MT |
May. 17 | Doximity's Shares Rise After Truist Securities Price Target Raise Following Fiscal Q4 Results | MT |
Summary
- The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
Strengths
- The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.
- The group's activity appears highly profitable thanks to its outperforming net margins.
- Thanks to a sound financial situation, the firm has significant leeway for investment.
- For the last twelve months, analysts have been gradually revising upwards their EPS forecast for the upcoming fiscal year.
- Predictions on business development from analysts polled by Standard & Poor's are tight. This results from either a good visibility into core activities or accurate earnings releases.
- Historically, the company has been releasing figures that are above expectations.
Weaknesses
- With an expected P/E ratio at 38.42 and 34.22 respectively for both the current and next fiscal years, the company operates with high earnings multiples.
- The company's "enterprise value to sales" ratio is among the highest in the world.
- In relation to the value of its tangible assets, the company's valuation appears relatively high.
- The valuation of the company is particularly high given the cash flows generated by its activity.
- Over the past twelve months, analysts' consensus has been significantly revised downwards.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Internet Services
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+1.60% | 5.28B | C+ | ||
+29.97% | 451B | B | ||
+33.56% | 280B | D+ | ||
+6.90% | 138B | A- | ||
+7.08% | 92.55B | C- | ||
+26.50% | 91.02B | B+ | ||
+72.82% | 64.41B | B- | ||
+11.82% | 45.22B | C+ | ||
+23.39% | 35.71B | C+ | ||
-10.68% | 31.89B | B |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- DOCS Stock
- Ratings Doximity, Inc.